Pharma Compliance Risk: How Inaccurate Physician Data Threatens Sunshine Act Reporting

Most of the risk in this series has been marketing waste. This one is different: the same bad record can also misattribute a legally reportable payment.

Everything in this series so far has been about marketing efficiency: wasted product, wasted shipping, wasted rep time. There's a separate risk hiding in the same bad data, and it doesn't show up in a marketing budget. It shows up in a federal compliance filing.

What Sunshine Act reporting actually requires

Under the Physician Payments Sunshine Act, manufacturers of drugs, devices, and biologics must report virtually every payment or transfer of value over $10 given to a physician or teaching hospital to CMS, annually, correctly attributed to the specific recipient. Physicians then get a review period before the data becomes public, during which they can flag and dispute anything reported incorrectly against their name.

That entire process depends on manufacturers correctly identifying which physician received what, using the same kind of identifying information, name, NPI, and practice affiliation, that this series has spent a lot of time on for entirely different reasons.

Where physician data errors become reporting errors

An inactive NPI, a stale affiliation, or a physician record that's drifted since the last check isn't just a marketing problem when it feeds into Sunshine Act reporting. It's exactly the kind of error that can turn a payment or transfer of value into a mismatch: attributed to the wrong practice, tied to an outdated affiliation, or flagged during a physician's review window as something that doesn't match their actual record.

The physicians most likely to catch these errors are the ones the report is about. That review period exists specifically so they can dispute exactly this kind of mistake before it becomes public.

What's actually at stake

This isn't a theoretical risk. CMS has the authority to audit reporting entities directly, and began doing so in fiscal year 2023. Penalties for inaccurate or unreported transfers of value scale per violation, and civil monetary caps for a pattern of violations have historically run well into seven figures annually. Enforcement has real precedent too: CMS and the Department of Justice have pursued multi-million dollar settlements against major manufacturers over Open Payments violations, on top of related penalties under other statutes.

None of that requires bad intent. It just requires a reporting process built on physician data that wasn't accurate at the moment it mattered most.

A different reason to get the data right

Every other post in this series makes the case that accurate physician data protects a marketing budget. This is the case that it also protects something with legal teeth: a reporting obligation with real penalties, real audits, and a review process specifically designed to surface the kind of errors bad data creates.

This is general context, not legal advice. Sunshine Act reporting obligations and penalty amounts are detailed and adjust periodically, so specifics should be confirmed with your own compliance or legal team.